GF Fund Management’s ResMed RMD Stock Holding History

GF Fund Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$893K	Hold	3,979	–	–	0.01%	196
2025 Q4	$958K	Sell	3,979 -73	-2%	-$18.7K	0.02%	198
2025 Q3	$1.11M	Buy	4,052 +446	+12%	+$122K	0.02%	193
2025 Q2	$930K	Sell	3,606 -26	-0.7%	-$6.2K	0.02%	214
2025 Q1	$813K	Hold	3,632	–	–	0.02%	216
2024 Q4	$831K	Buy	+3,632	New	+$875K	0.02%	206

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GF Fund Management's RMD Position: Q1 2026 in Review

GF Fund Management held its ResMed (RMD) position steady in Q1 2026 at 3,979 shares worth $893K. The position accounts for 0.01% of the portfolio, ranked #196.

GF Fund Management first reported a position in RMD in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.11M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

GF Fund Management held 3,979 shares of ResMed worth $893K as of Q1 2026.
GF Fund Management left its ResMed share count unchanged in Q1 2026.
ResMed made up 0.01% of GF Fund Management's portfolio in Q1 2026, its #196 holding.
GF Fund Management first reported a position in ResMed in Q4 2024 and has held it in 6 quarters since.
GF Fund Management's ResMed position peaked at $1.11M in Q3 2025.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.